BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/19/2025 8:32:40 AM | Browse: 4 | Download: 19
 |
Received |
|
2025-05-21 06:21 |
|
Peer-Review Started |
|
2025-05-22 02:54 |
|
First Decision by Editorial Office Director |
|
2025-06-07 02:10 |
|
Return for Revision |
|
2025-06-07 02:10 |
|
Revised |
|
2025-06-11 15:43 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-10-10 02:40 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-10-11 03:49 |
|
Articles in Press |
|
2025-10-11 03:49 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-11-28 09:30 |
|
Publish the Manuscript Online |
|
2025-12-19 08:32 |
| ISSN |
2220-315x (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Minireviews |
| Article Title |
Dual incretin analogue tirzepitide - SURMOUNTing the challenge of obesity induced obstructive sleep apnea
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jyoti Bajpai, Mehul Saxena, Utkarsh Agarwal and Akshyaya Pradhan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Akshyaya Pradhan, Department of Cardiology, King George’s Medical University, Shahmina Road, Chowk, Lucknow 226003, Uttar Pradesh, India. akshyaya33@gmail.com |
| Key Words |
Apnea hypopnea index; Weight loss; Continuous positive airway pressure; Glucagon like receptor -1; SURMOUNT-1 trial |
| Core Tip |
Obstructive sleep apnea (OSA) is a serious sleep disorder often caused by obesity. Standard treatments like continuous positive airway pressure can help, but many people struggle to use them long term. Tirzepatide, a new medication that targets both glucagon-like peptide-1 and gastric inhibitory polypeptide receptors, offers a different approach. By helping with significant weight loss and improving breathing during sleep, tirzepatide has shown strong results in the SURMOUNT-OSA trial, making it the first approved drug to directly treat obesity-related OSA. |
| Publish Date |
2025-12-19 08:32 |
| Citation |
Bajpai J, Saxena M, Agarwal U, Pradhan A. Dual incretin analogue tirzepitide - SURMOUNTing the challenge of obesity induced obstructive sleep apnea. World J Exp Med 2025; 15(4): 109762 |
| URL |
https://www.wjgnet.com/2220-315x/full/v15/i4/109762.htm |
| DOI |
https://dx.doi.org/10.5493/wjem.v15.i4.109762 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
